Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
These compounds have shown promise in improving mental clarity, sharpening focus, and helping the brain recover from stress or damage
However, certain circumstances may warrant testing including pre-existing liver or kidney conditions where monitoring organ function during therapy provides appropriate oversight, specific health concerns that might benefit from objective biomarker assessment, desire to objectively measure oxidative stress markers or glutathione status before and during therapy, and medical conditions requiring monitoring for safety reasons
However, they suggest that ALCAR may be an important antidepressant therapy, either alone or in conjunction with other mood enhancers, especially in those with other medical conditions who may not tolerate high dose antidepressants
Frequency Considerations BPC-157 has a relatively short half-life of less than 30 minutes, which raises questions about optimal dosing frequency
Also known as Bepecin, BPC 157, Body Protection Compound 157, Pentadecapeptide BPC-157, PCO-02 Evidence records Studies, registries, reviews, and regulatory records Registered human trials NCT02637284 is a Phase 1 oral safety and pharmacokinetics study in healthy volunteers
